Literature DB >> 21775515

Impaired humoral response to vaccines among HIV-exposed uninfected infants.

Beatriz Mariana Abramczuk1, Taís Nitsch Mazzola, Yara Maria Franco Moreno, Tatiane Queiroz Zorzeto, Wagner Quintilio, Paulo Silva Wolf, Maria Heloisa Blotta, André Moreno Morcillo, Marcos Tadeu Nolasco da Silva, Maria Marluce Dos Santos Vilela.   

Abstract

Little is known about the vaccine protective response for infants born from HIV-infected mothers. We evaluated the antibody response to hepatitis B, tetanus, and diphtheria vaccine in vertically HIV-exposed uninfected infants and compared them to those of control infants not exposed to the virus. The quantitative determination of specific neutralizing antibodies against hepatitis B, diphtheria, and tetanus were performed blindly on serum samples. The results showed that 6.7% of the HIV-exposed uninfected individuals were nonresponders to hepatitis B vaccine (anti-HBs titer, <10 mIU/ml), and 64.4% were very good responders (anti-HBs titer, ≥1,000 mIU/ml), whereas only 3.6% of the nonexposed infants were nonresponders (χ(2)=10.93; 1 df). The HIV-exposed uninfected infants showed protective titers for diphtheria and tetanus but lower geometric mean anti-tetanus titers compared to those of the HIV-unexposed infants. Our data point to the necessity of evaluating vaccine immune responses in these children and reinforced that alterations in lymphocyte numbers and functions reported for newborns from HIV-infected mothers interfere with the vaccine response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775515      PMCID: PMC3165213          DOI: 10.1128/CVI.05065-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  38 in total

1.  Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts.

Authors:  S D Nielsen; D L Jeppesen; L Kolte; D R Clark; T U Sørensen; A M Dreves; A K Ersbøll; L P Ryder; N H Valerius; J O Nielsen
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

2.  T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV.

Authors:  M Clerici; M Saresella; F Colombo; S Fossati; N Sala; D Bricalli; M L Villa; P Ferrante; L Dally; A Vigano'
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

3.  Potency control of diphtheria component in adsorbed vaccines by in vitro neutralization tests.

Authors:  Rugimar Marcovistz; Denise C S Matos; Ricardo A Georgini; Dirce Sakauchi
Journal:  Biologicals       Date:  2002-06       Impact factor: 1.856

4.  Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test.

Authors:  Denise Cristina Souza Matos; Rugimar Marcovistz; Pedro Hernan Cabello; Ricardo Amaral Georgini; Dirce Sakauchi; Luciana Leite da Silva
Journal:  Mem Inst Oswaldo Cruz       Date:  2002-10-15       Impact factor: 2.743

Review 5.  Immunization of children at risk of infection with human immunodeficiency virus.

Authors:  William J Moss; C John Clements; Neal A Halsey
Journal:  Bull World Health Organ       Date:  2003-03-11       Impact factor: 9.408

6.  Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants.

Authors:  Jérôme Le Chenadec; Marie-Jeanne Mayaux; Chantal Guihenneuc-Jouyaux; Stéphane Blanche
Journal:  AIDS       Date:  2003-09-26       Impact factor: 4.177

7.  Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort.

Authors:  Béatrice Barret; Marc Tardieu; Pierre Rustin; Catherine Lacroix; Brigitte Chabrol; Isabelle Desguerre; Catherine Dollfus; Marie-Jeanne Mayaux; Stéphane Blanche
Journal:  AIDS       Date:  2003-08-15       Impact factor: 4.177

8.  Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.

Authors:  Pimolrat Thaithumyanon; Santi Punnahitananda; Pramote Praisuwanna; Usa Thisyakorn; Kiat Ruxrungtham
Journal:  J Med Assoc Thai       Date:  2002-03

9.  Feasibility study of the immunogenicity and safety of a novel DTPw/Hib (PRP-T) Brazilian combination compared to a licensed vaccine in healthy children at 2, 4, and 6 months of age.

Authors:  SueAnn Costa Clemens; Tania Azevedo; Akira Homma
Journal:  Rev Soc Bras Med Trop       Date:  2003-07-31       Impact factor: 1.581

10.  The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns.

Authors:  Eliane Borges-Almeida; Helaine M B P M Milanez; Maria Marluce S Vilela; Fernanda G P Cunha; Beatriz M Abramczuk; Suiellen C Reis-Alves; Konradin Metze; Irene Lorand-Metze
Journal:  BMC Infect Dis       Date:  2011-02-03       Impact factor: 3.090

View more
  35 in total

1.  Do children exposed to human immunodeficiency virus but not infected actually have a more robust response to hepatitis B vaccination than their nonexposed peers?

Authors:  Olivia Swann; Ewen M Harrison
Journal:  Clin Vaccine Immunol       Date:  2012-02

Review 2.  Immunotherapies to prevent mother-to-child transmission of HIV.

Authors:  Mark D Hicar
Journal:  Curr HIV Res       Date:  2013-03       Impact factor: 1.581

3.  Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection.

Authors:  George K Siberry; Kunjal Patel; William J Bellini; Brad Karalius; Murli U Purswani; Sandra K Burchett; William A Meyer; Sun Bae Sowers; Angela Ellis; Russell B Van Dyke
Journal:  Clin Infect Dis       Date:  2015-06-09       Impact factor: 9.079

Review 4.  The Immune System of HIV-Exposed Uninfected Infants.

Authors:  Bahaa Abu-Raya; Tobias R Kollmann; Arnaud Marchant; Duncan M MacGillivray
Journal:  Front Immunol       Date:  2016-09-28       Impact factor: 7.561

5.  Measles Immunity at 4.5 Years of Age Following Vaccination at 9 and 15-18 Months of Age Among Human Immunodeficiency Virus (HIV)-infected, HIV-exposed-uninfected, and HIV-unexposed Children.

Authors:  Eleonora A M L Mutsaerts; Marta C Nunes; Martijn N van Rijswijk; Kerstin Klipstein-Grobusch; Kennedy Otwombe; Mark F Cotton; Avy Violari; Shabir A Madhi
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

6.  Management of diarrhea in HIV-affected infants and children.

Authors:  Patricia B Pavlinac; Kirkby D Tickell; Judd L Walson
Journal:  Expert Rev Anti Infect Ther       Date:  2014-11-11       Impact factor: 5.091

7.  Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.

Authors:  Ingrid T Katz; Erin Leister; Deborah Kacanek; Michael D Hughes; Arlene Bardeguez; Elizabeth Livingston; Alice Stek; David E Shapiro; Ruth Tuomala
Journal:  Ann Intern Med       Date:  2015-01-20       Impact factor: 25.391

Review 8.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

Review 9.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Effect of multivitamin supplementation on measles vaccine response among HIV-exposed uninfected Tanzanian infants.

Authors:  Christopher R Sudfeld; Christopher Duggan; Alex Histed; Karim P Manji; Simin N Meydani; Said Aboud; Molin Wang; Edward L Giovannucci; Wafaie W Fawzi
Journal:  Clin Vaccine Immunol       Date:  2013-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.